Ann: Elixinol continues to build Leadership team, page-2

especially interesting

new ceo obviously about structure and process

this is sometimes missing as entrepreneur driven ventures often don't cope as they grow

structure, process and institutionalisation allow company to grow to next level

4c will be so interesting to see if the sales dip from axing white label sales has stabilised or turned the corner at all

the anecdotal information on US brick and mortar pharmacy sales I think is material / I understand that was over ordered in first instance but was actually proven to sell out immediately more or less so I expect the 4c could be ok

anyway an interesting situation as clearly company having some growing issues with white label and management changes so will see if they emerge stronger ?